Skip to main content
. 2018 Feb 6;24:758–767. doi: 10.12659/MSM.905903

Figure 4.

Figure 4

The impact of EVI1 expression and NPM1 mutation status on RFS in FLT3-ITD (−) patients. (A) Patients were grouped according to EVI1 expression. (B) Patients were grouped according to both EVI1 expression and NPM1 mutation status.